Brett Zbar, M.D.

Managing Director, Foresite Capital

Dr. Zbar joined Foresite Capital in 2015 with more than 15 years of healthcare private equity and consulting experience. Prior to joining Foresite, Brett was a partner at Aisling Capital, a life sciences-dedicated venture capital and private equity firm that also manages the investments of the Perseus-Soros Bio Pharmaceutical Fund. Over the course of more than a decade at Aisling Capital, Brett served as a member of the Board of Directors of Aragon Pharmaceuticals, Seragon Pharmaceuticals and Planet Biopharmaceuticals, and as a board observer at Catalent Pharma Solutions, among other companies. Previously, Brett was an associate principal at McKinsey & Company and a senior member of the Pharmaceuticals and Medical Products practice.

Brett received his M.D. from Harvard Medical School and graduated Yale magna cum laude with Distinction in English and Molecular Biophysics & Biochemistry.